Professor John Newell-Price

MA, PhD, FRCP

Clinical Medicine, School of Medicine and Population Health

Professor of Endocrinology

Honorary Consultant Physician

j.newellprice@sheffield.ac.uk
+44 114 215 9018

+44 114 271 2475 (fax)

EU07, E Floor, The Medical School

Full contact details

Professor John Newell-Price
Clinical Medicine, School of Medicine and Population Health
EU07, E Floor
The Medical School
Beech Hill Road
Sheffield
S10 2RX

Profile

For enquiries, please contact - ClinMed-Operational@sheffield.ac.uk

John Newell-Price trained in medicine at the University of Cambridge and then the Royal London Hospital. He did his specialist training in endocrinology at St. Bartholomew's Hospital, London, where he was an MRC Training Fellow from 1995-1998. He was appointed Senior Lecturer and Honorary Consultant Physician at the University of Sheffield in 2000.

The focus of both his clinical and basic research is glucocorticoids. His group has identified important aspects of epigenetic regulation of proopiomelanocortin, the key regulator of the hypothalamic-pituitary-adrenal axis, and now is using this information to design strategies to modify over-expression in conditions of excess hormone secretion, such as Cushing's disease.

The clinical research programme has been investigating means of inhibiting excess ACTH in man and improving cortisol replacement in adrenally insufficient patients. This has led to the testing of Chronocort, a new and modified-release form of hydrocortisone, in Phase I studies, which has proven to replicate the normal circadian rhythm of cortisol.

Other work focuses on the diagnostic and management strategies for patients with Cushing's syndrome, and those also for patients with neuroendocrine tumours.

In the Healthcare Trust, John chairs the Pituitary and Neuroendocrine Tumour Multidisciplinary Teams.

Current PhD Opportunities

Development of a Long Acting Parathyroid Hormone Fusion for the Treatment of Hypoparathyroidism

Publications

Show: Featured publications All publications

Featured publications

Journal articles

Pivonello R, Fleseriu M, Newell-Price J, Bertagna X, Findling J, Shimatsu A, Gu F, Auchus R, Leelawattana R, Lee EJ , Kim JH et al (2020) Efficacy and safety of osilodrostat in patients with Cushing's disease (LINC 3): a multicentre phase III study with a double-blind, randomised withdrawal phase. The Lancet Diabetes & Endocrinology, 8(9), 748-761. View this article in WRRO
Newell-Price J, Nieman LK, Reincke M & Tabarin A (2020) Endocrinology in the time of COVID-19: Management of Cushing’s syndrome. European Journal of Endocrinology, 183(1), G1-G7. View this article in WRRO
Newell-Price J, Pivonello R, Tabarin A, Fleseriu M, Witek P, Gadelha MR, Petersenn S, Tauchmanova L, Ravichandran S, Gupta P , Lacroix A et al (2020) Use of late-night salivary cortisol to monitor response to medical treatment in Cushing’s disease. European Journal of Endocrinology, 182(2), 207-217. View this article in WRRO
Feelders RA, Newell-Price J, Pivonello R, Nieman LK, Hofland LJ & Lacroix A (2019) Advances in the medical treatment of Cushing's syndrome. The Lancet Diabetes & Endocrinology, 7(4), 300-312.
Sims-Williams HP, Rajapaksa K, Sinha S, Radatz M, Walton L, Yianni J & Newell-Price J (2019) Radiosurgery as primary management for acromegaly. Clinical Endocrinology, 90(1), 114-121.
Daniel E, Debono M, Caunt S, Girio-Fragkoulakis C, Walters SJ, Akker SA, Grossman AB, Trainer PJ & Newell-Price J (2018) A prospective longitudinal study of Pasireotide in Nelson’s syndrome. Pituitary, 21(3), 247-255. View this article in WRRO
Lacroix A, Gu F, Gallardo W, Pivonello R, Yu Y, Witek P, Boscaro M, Salvatori R, Yamada M, Tauchmanova L , Roughton M et al (2018) Efficacy and safety of once-monthly pasireotide in Cushing's disease: a 12 month clinical trial. The Lancet Diabetes and Endocrinology, 6(1), 17-26. View this article in WRRO
Debono M, Harrison RF, Chadarevian R, Gueroult C, Abitbol J-L & Newell-Price J (2017) Resetting the Abnormal Circadian Cortisol Rhythm in Adrenal Incidentaloma Patients With Mild Autonomous Cortisol Secretion. Journal of Clinical Endocrinology & Metabolism, 102(9), 3461-3469. View this article in WRRO
Daniel E, Jones R, Bull M & Newell-Price J (2016) Rapid-sequence MRI for long-term surveillance for paraganglioma and phaeochromocytoma in patients with succinate dehydrogenase mutations. European Journal of Endocrinology, 175, 561-570. View this article in WRRO
Fassnacht M, Arlt W, Bancos I, Dralle H, Newell-Price J, Sahdev A, Tabarin A, Terzolo M, Tsagarakis S & Dekkers OM (2016) Management of adrenal incidentalomas: European Society of Endocrinology Clinical Practice Guideline in collaboration with the European Network for the Study of Adrenal Tumors. European Journal of Endocrinology, 175(2), G1-G34.
Daniel E, Aylwin S, Mustafa O, Ball S, Munir A, Boelaert K, Chortis V, Cuthbertson DJ, Daousi C, Rajeev SP , Davis J et al (2015) Effectiveness of Metyrapone in Treating Cushing's Syndrome: A Retrospective Multicenter Study in 195 Patients. The Journal of Clinical Endocrinology & Metabolism, 100(11), 4146-4154. View this article in WRRO
Nieman LK, Biller BMK, Findling JW, Murad MH, Newell-Price J, Savage MO & Tabarin A (2015) Treatment of Cushing's Syndrome: An Endocrine Society Clinical Practice Guideline. The Journal of Clinical Endocrinology & Metabolism, 100(8), 2807-2831.
Debono M, Bradburn M, Bull M, Harrison B, Ross RJ & Newell-Price J (2014) Cortisol as a Marker for Increased Mortality in Patients with Incidental Adrenocortical Adenomas. The Journal of Clinical Endocrinology & Metabolism, 99(12), 4462-4470.
Debono M, Prema A, Hughes TJB, Bull M, Ross RJ & Newell-Price J (2013) Visceral fat accumulation and postdexamethasone serum cortisol levels in patients with adrenal incidentaloma.. J Clin Endocrinol Metab, 98(6), 2383-2391.
Debono M, Chadarevian R, Eastell R, Ross RJ & Newell-Price J (2013) Mifepristone reduces insulin resistance in patient volunteers with adrenal incidentalomas that secrete low levels of cortisol: a pilot study.. PLoS One, 8(4), e60984. View this article in WRRO
Colao A, Petersenn S, Newell-Price J, Findling JW, Gu F, Maldonado M, Schoenherr U, Mills D, Salgado LR, Biller BMK & Pasireotide B2305 Study Group (2012) A 12-month phase 3 study of pasireotide in Cushing's disease.. N Engl J Med, 366(10), 914-924.

All publications

Journal articles

Newell-Price J, Fleseriu M, Pivonello R, Feelders RA, Gadelha MR, Lacroix A, Witek P, Heaney AP, Piacentini A, Pedroncelli AM & Biller BMK (2024) Improved Clinical Outcomes During Long-term Osilodrostat Treatment of Cushing Disease With Normalization of Late-night Salivary Cortisol and Urinary Free Cortisol. Journal of the Endocrine Society, 9(1), bvae201.
Ross RJM, Merke DP, Mallappa A, Arlt W, de la Perriere AB, Linden Hirschberg A, Newell-Price JDC, Prete A, Rees A, Reisch N , Quinkler M et al (2024) 7061 Incidence of Adrenal Crisis In Congenital Adrenal Hyperplasia (CAH) Patients During A Prospective Monitored Long-Term Study Of Modified-Release Hydrocortisone (MRHC) Capsules, (Efmody). Journal of the Endocrine Society, 8(Supplement_1).
Riaz B, Muraleedharan V, Fernando D, Balasubramanian S & Newell-Price J (2024) 7898 A Case of Dual Secreting Adrenal Lesion With Multiple Complications Resulting From Hormonal Abnormalities. Journal of the Endocrine Society, 8(Supplement_1).
Prete A, Theiler-Schwetz V, Arlt W, Oana Chifu I, Harbeck B, Napier C, Newell-Price JDC, Rees A, Reisch N, Karl Stalla G , Aslam N et al (2024) 12670 CHAMPAIN Study: Initial Results From A Phase II Study Of Efficacy, Safety And Tolerability Of Modified-release Hydrocortisones: Chronocort® (Efmody®) Versus Plenadren®, In Primary Adrenal Insufficiency. Journal of the Endocrine Society, 8(Supplement_1).
Fleseriu M, Pivonello R, Newell-Price J, Gadelha M, Auchus RJ, Feelders R, Lacroix A, Shimatsu A, Witek P, Bex M , Piacentini A et al (2024) 6907 Continued Improvements in Hypertension and Diabetes During Long-Term Osilodrostat Therapy in Patients with Cushing’s Disease: A Pooled Analysis from the Phase III LINC 3 and LINC 4 Studies. Journal of the Endocrine Society, 8(Supplement_1).
Prete A, Theiler-Schwetz V, Arlt W, Chifu IO, Harbeck B, Napier C, Newell-Price JD, Rees A, Reisch N, Stalla GK , Aslam N et al (2024) 9341 CHAMPAIN Study: Initial Results From A Phase II Study Of Efficacy, Safety And Tolerability Of Modified-release Hydrocortisones: Chronocort® (Efmody®) Versus Plenadren®, In Primary Adrenal Insufficiency. Journal of the Endocrine Society, 8(Supplement_1).
Berry S, Iqbal A, Newell-Price JDC & Debono M (2024) 6927 Metyrapone To Reset The Nocturnal Cortisol Rhythm In Mild Autonomous Cortisol Secretion (MACS) - Safety And Impact On Cardiometabolic Risk Factors. Journal of the Endocrine Society, 8(Supplement_1).
Prete A, Theiler-Schwetz V, Arlt W, Oana Chifu I, Harbeck B, Napier C, Newell-Price JDC, Rees A, Reisch N, Karl Stalla G , Aslam N et al (2024) 7692 Morning Cortisol Levels In Patients With Established Primary Adrenal Insufficiency. Journal of the Endocrine Society, 8(Supplement_1).
Lawrence NR, Krone NP, Dawson JF, Lang ZQ, Arlt W, Brac de la Perriere A, Hirschberg AL, Juul A, Merke DP, Newell-Price JD , Prete A et al (2024) 6437 Analysis of 17-OH-progesterone (17OHP) and androstenedione (A4) profiles to rationalise biochemical monitoring of CAH patients. Journal of the Endocrine Society, 8(Supplement_1). View this article in WRRO
Rees AD, Merke DP, Arlt W, Brac de la Perrière A, Linden-Hirschberg A, Juul A, Newell-Price J, Prete A, Reisch N, Stikkelbroeck NM , Touraine P et al (2024) Comparison of modified-release hydrocortisone capsules versus prednisolone in the treatment of congenital adrenal hyperplasia. Endocrine Connections, EC-24.
Kelsall A & Newell-Price J (2024) Maximizing the sensitivity of bilateral inferior petrosal sinus sampling. Journal of the Endocrine Society, 8(7). View this article in WRRO
Arshad MF, Elder C, Newell-Price J, Ross R & Debono M (2024) A retrospective study on weaning glucocorticoids and recovery of the hypothalamic-pituitary-adrenal axis. The Journal of Clinical Endocrinology & Metabolism. View this article in WRRO
Newell-Price J (2023) Testing for Arginine Vasopressin Deficiency. New England Journal of Medicine, 389(20), 1920-1921.
Fahad AM, Lawrence N, Elder C, Newell-Price J, Ross R & Debono M (2023) Defining the basal serum cortisol cut-off for weaning patients off glucocorticoids in suspected tertiary adrenal insufficiency. Endocrine Abstracts, 94. View this article in WRRO
Lawrence NR, Arshad MF, Pofi R, Ashby S, Dawson J, Tomlinson JW, Newell-Price J, Ross RJ, Elder CJ & Debono M (2023) Multivariable model to predict an ACTH stimulation test to diagnose adrenal insufficiency using previous test results. Journal of the Endocrine Society, 7(12). View this article in WRRO
Pelsma ICM, Fassnacht M, Tsagarakis S, Terzolo M, Tabarin A, Sahdev A, Newell-Price J, Marina L, Lorenz K, Bancos I , Arlt W et al (2023) Comorbidities in mild autonomous cortisol secretion and the effect of treatment: systematic review and meta-analysis. European Journal of Endocrinology, 189(4), S88-S101.
Ross RJM, Merke DP, Mallappa A, Arlt W, de la Perriere AB, Hirschberg AL, Juul A, Newell-Price JDC, Perry CG, Prete A , Rees A et al (2023) SAT304 Improved Biochemical Control With Dose Reduction In Chronic Glucocorticoid Therapy: A Phase III Extension Study Of Chronocort (Efmody) In The Treatment Of Congenital Adrenal Hyperplasia (CAH). Journal of the Endocrine Society, 7(Supplement_1).
Lawrence NR, Keevil BG, Elder C, Fearnside J, Caunt S, Dixon S, Newell-Price JDC, Ross RJM & Debono M (2023) OR30-01 Waking Salivary 11-hydroxyandrostenedione And Cortisone As A Novel Non-invasive Test For Adrenal Insufficiency. Journal of the Endocrine Society, 7(Supplement_1), bvad114.351.
Hamblin R, Fountas A, Lithgow K, Loughrey PB, Bonanos E, Shinwari SK, Mitchell K, Shah S, Grixti L, Matheou M , Isand K et al (2023) Natural history of non-functioning pituitary microadenomas: results from the UK non-functioning pituitary adenoma consortium. European Journal of Endocrinology, 189(1), 87-95.
Cozzolino A, Hasenmajer V, Newell-Price J & Isidori AM (2023) COVID-19 pandemic and adrenals: deep insights and implications in patients with glucocorticoid disorders. Endocrine, 82, 1-14. View this article in WRRO
Fassnacht M, Tsagarakis S, Terzolo M, Tabarin A, Sahdev A, Newell-Price J, Pelsma I, Marina L, Lorenz K, Bancos I , Arlt W et al (2023) European Society of Endocrinology clinical practice guidelines on the management of adrenal incidentalomas, in collaboration with the European Network for the Study of Adrenal Tumors. European Journal of Endocrinology, 189(1), G1-G42.
Tschaidse L, Reisch N, Arlt W, Brac de la Perriere A, Linden Hirschberg A, Juul A, Mallappa A, Merke DP, Newell-Price JDC, Perry CG , Prete A et al (2023) Modified-release hydrocortisone is associated with lower plasma renin activity in patients with salt-wasting congenital adrenal hyperplasia. European Journal of Endocrinology, 188(1), 109-117.
Debono M, Elder CJ, Lewis J, Fearnside J, Caunt S, Dixon S, Jacques RM, Newell-Price J, Whitaker MJ, Keevil B & Ross RJ (2023) Home waking salivary cortisone to screen for adrenal insufficiency. NEJM Evidence, 2(2).
Arima H, Bichet DG, Cheetham T, Christ-Crain M, Drummond J, Gurnell M, Levy M, McCormack A, Newell-Price J, Verbalis JG , Wass J et al (2022) Changing the name of diabetes insipidus. Pituitary, 25(6), 777-779.
Atila C, Loughrey PB, Garrahy A, Winzeler B, Refardt J, Gildroy P, Tarig Hamza MET, Pal A, Thompson CJ, Verbalis JG , Hunter SJ et al (2022) LBMON62 Central Diabetes Insipidus From A Patients’ Perspective- From Management To Psychological Co-morbidities And Re-naming Of The Condition. Journal of the Endocrine Society, 6(Supplement_1), A474-A475.
Arima H, Cheetham T, Christ-Crain M, Cooper D, Gurnell M, Drummond JB, Levy M, McCormack AI, Verbalis J, Newell-Price J & Wass JAH (2022) Changing the name of diabetes insipidus: a position statement of The Working Group for Renaming Diabetes Insipidus. Endocrine Journal.
Arima H, Cheetham T, Christ-Crain M, Cooper D, Gurnell M, Drummond JB, Levy M, McCormack AI, Verbalis J, Newell-Price J & Wass JAH (2022) Changing the name of diabetes insipidus: a position statement of The Working Group for Renaming Diabetes Insipidus. Endocrine Connections, 11(11).
Arima H, Cheetham T, Christ-Crain M, Cooper DL, Drummond JB, Gurnell M, Levy M, McCormack A, Newell-Price JD, Verbalis JG & Wass J (2022) Changing the name of diabetes insipidus: a position statement of the working group to consider renaming diabetes insipidus. Archives of Endocrinology and Metabolism.
Fleseriu M, Newell-Price J, Pivonello R, Shimatsu A, Auchus RJ, Scaroni C, Belaya Z, Feelders RA, Vila G, Houde G , Walia R et al (2022) Long-term outcomes of osilodrostat in Cushing’s disease: LINC 3 study extension. European Journal of Endocrinology, 187(4), 531-541.
Atila C, Loughrey PB, Garrahy A, Winzeler B, Refardt J, Gildroy P, Hamza M, Pal A, Verbalis JG, Thompson CJ , Hemkens LG et al (2022) Central diabetes insipidus from a patient's perspective: management, psychological co-morbidities, and renaming of the condition: results from an international web-based survey. Lancet Diabetes and Endocrinology.
Fallo F, Di Dalmazi G, Beuschlein F, Biermasz NR, Castinetti F, Elenkova A, Fassnacht M, Isidori AM, Kastelan D, Korbonits M , Newell-Price J et al (2022) Diagnosis and management of hypertension in patients with Cushing's syndrome: a position statement and consensus of the Working Group on Endocrine Hypertension of the European Society of Hypertension. Journal of Hypertension, 40(11), 2085-2101.
Fleseriu M, Castinetti F, Gadelha M, Giustina A, Lacroix A, Melmed S, Newell-Price J, Pivonello R, Reincke M & Biller BMK (2022) Osilodrostat for the treatment of Cushing's disease: efficacy, stability, and persistence – Authors' reply. The Lancet Diabetes & Endocrinology, 10(6), 385-387.
Deutschbein T, Reimondo G, Di Dalmazi G, Bancos I, Patrova J, Vassiliadi DA, Nekić AB, Debono M, Lardo P, Ceccato F , Petramala L et al (2022) Age-dependent and sex-dependent disparity in mortality in patients with adrenal incidentalomas and autonomous cortisol secretion : an international, retrospective, cohort study. The Lancet Diabetes & Endocrinology.
Bennet WM, Elamin A & Newell‐Price JD (2022) Subacute thyroiditis following COVID‐19 vaccination : case report and Society for Endocrinology survey. Clinical Endocrinology.
Ramezanipour N, Esfahani SHZ, Eastell R, Newell-Price J, Trevitt G, Ross RJ & Wilkinson IR (2022) Development of a hypoparathyroid male rodent model for testing delayed-clearance PTH molecules. Endocrinology, 163(2). View this article in WRRO
Newey PJ & Newell-Price J (2022) MEN1 surveillance guidelines : time to (re)think?. Journal of the Endocrine Society, 6(2), 1-5.
Cavalli A, Mirza S, Newell-Price J & Sinha S (2022) Bigger isn’t better! Macroadenomas in Cushing’s disease, a single center experience and outcomes. Brain and Spine, 2, 101289-101289.
Fleseriu M, Auchus R, Bancos I, Ben-Shlomo A, Bertherat J, Biermasz NR, Boguszewski CL, Bronstein MD, Buchfelder M, Carmichael JD , Casanueva FF et al (2021) Consensus on diagnosis and management of Cushing's disease: a guideline update. The Lancet Diabetes & Endocrinology, 9(12), 847-875.
Newell-Price J, Huatan H, Quirke J, Porter J, Daniel E, Mumdzic E, Voet B, Keevil B, Whitaker MJ & Ross RJ (2021) An oral lipidic native testosterone formulation that is absorbed independent of food. European Journal of Endocrinology, 185(5), 607-615. View this article in WRRO
Williams ST, Chatzikyriakou P, Carroll PV, McGowan BM, Velusamy A, White G, Obholzer R, Akker S, Tufton N, Casey RT , Maher ER et al (2021) SDHC phaeochromocytoma and paraganglioma: A UK‐wide case series. Clinical Endocrinology.
Castinetti F, Nieman LK, Reincke M & Newell-Price J (2021) Approach to the Patient Treated with Steroidogenesis Inhibitors. The Journal of Clinical Endocrinology & Metabolism, 106(7), 2114-2123.
Kelsall A & Newell-Price J (2021) Cushing's syndrome. Medicine.
Sims-Williams HP, Rajapaksa K, Yianni J, Walton L, Sinha S, Radatz M, Herbert E, Bradburn M & Newell-Price J (2021) Long-term safety of gamma knife radiosurgery (SRS) for acromegaly.. Pituitary.
Eltumi H, Whatmore J, Kemp EH & Newell-Price J (2021) Antisense Oligonucleotides as a Novel Therapy for Cushing’s Disease. Journal of the Endocrine Society, 5(Suppl 1), a532-a533.
Reincke M, Albani A, Assie G, Bancos I, Brue T, Buchfelder M, Chabre O, Ceccato F, Daniele A, Detomas M , Di Dalmazi G et al (2021) Corticotroph tumor progression after bilateral adrenalectomy (Nelson’s syndrome): systematic review and expert consensus recommendations. European Journal of Endocrinology, 184(3), P1-P16.
Merke DP, Mallappa A, Arlt W, Brac de la Perriere A, Lindén Hirschberg A, Juul A, Newell-Price J, Perry CG, Prete A, Rees DA , Reisch N et al (2021) Modified-release hydrocortisone in congenital adrenal hyperplasia. The Journal of Clinical Endocrinology & Metabolism.
Crona J, Baudin E, Terzolo M, Chrisoulidou A, Angelousi A, Ronchi CL, Oliveira CL, Nieveen van Dijkum EJM, Ceccato F, Borson-Chazot F , Reimondo G et al (2021) ENSAT registry-based randomized clinical trials for adrenocortical carcinoma. European Journal of Endocrinology, 184(2), R51-R59.
Pivonello R, Fleseriu M, Newell-Price J, Bertagna X, Findling J, Shimatsu A, Gu F, Auchus R, Leelawattana R, Lee EJ , Kim JH et al (2020) Efficacy and safety of osilodrostat in patients with Cushing's disease (LINC 3): a multicentre phase III study with a double-blind, randomised withdrawal phase. The Lancet Diabetes & Endocrinology, 8(9), 748-761. View this article in WRRO
(2020) Correction to Lancet Diabetes Endocrinol 2020; 8: 762–72. The Lancet Diabetes & Endocrinology, 8(9), e4-e4.
Newell-Price J, Nieman LK, Reincke M & Tabarin A (2020) Endocrinology in the time of COVID-19: Management of Cushing’s syndrome. European Journal of Endocrinology, 183(1), G1-G7. View this article in WRRO
Merke DP, Mallappa A, Arlt W, de la Perriere AB, Hirschberg AL, Juul A, Newell-Price JDC, Perry CG, Prete A, Rees A , Reisch N et al (2020) OR25-02 A phase 3 study of a modified-release hydrocortisone in the treatment of congenital adrenal hyperplasia. Journal of the Endocrine Society, 4(Supplement_1). View this article in WRRO
Newell-Price JDC, Porter J, Quirke J, Daniel E, Mumdzic E & Ross RJM (2020) SAT-LB6 First Human Trial of an Oral Native Testosterone Shows Physiological Levels of Testosterone and Dht in Both Fasted and Fed State in Hypogonadal Men. Journal of the Endocrine Society, 4(Supplement_1).
Ramezani-Pour N, Esfahani SHZ, Pradhananga S, Newell-Price JDC, Ross RJM & Wilkinson IR (2020) SAT-396 A Non-Surgical Animal Model of Hypoparathyroidism for Testing PTH Analogues. Journal of the Endocrine Society, 4(Supplement_1).
Newell-Price J, Pivonello R, Tabarin A, Fleseriu M, Witek P, Gadelha MR, Petersenn S, Tauchmanova L, Ravichandran S, Gupta P , Lacroix A et al (2020) Use of late-night salivary cortisol to monitor response to medical treatment in Cushing’s disease. European Journal of Endocrinology, 182(2), 207-217. View this article in WRRO
Kelsall A, Iqbal A & Newell-Price J (2020) Adrenal incidentaloma: cardiovascular and metabolic effects of mild cortisol excess. Gland Surgery, 9(1), 94-104.
Fountas A, Lim ES, Drake WM, Powlson AS, Gurnell M, Martin NM, Seejore K, Murray RD, MacFarlane J, Ahluwalia R , Swords F et al (2020) Outcomes of Patients with Nelson’s Syndrome after Primary Treatment: A Multicenter Study from 13 UK Pituitary Centers. The Journal of Clinical Endocrinology & Metabolism, 105(5), 1527-1537.
Fleseriu M, Petersenn S, Biller BMK, Kadioglu P, De Block C, T'Sjoen G, Vantyghem MC, Tauchmanova L, Wojna J, Roughton M , Lacroix A et al (2019) Long‐term efficacy and safety of once‐monthly pasireotide in Cushing's disease: A Phase III extension study. Clinical Endocrinology, 91(6), 776-785. View this article in WRRO
Kelsall A & Newell-Price J (2019) Cushing's disease—from Minnie G to key issues in the early 21st century. The Lancet Diabetes & Endocrinology, 7(12), 959-964.
Challis BG, Casey RT, Grossman A, Newell‐Price J, Newey P & Thakker RV (2019) What is the appropriate management of nonfunctioning pancreatic neuroendocrine tumours disclosed on screening in adult patients with multiple endocrine neoplasia type 1?. Clinical Endocrinology, 91(6), 708-715.
Valassi E, Tabarin A, Brue T, Feelders RA, Reincke M, Netea-Maier R, Tóth M, Zacharieva S, Webb SM, Tsagarakis S , Chanson P et al (2019) High mortality within 90 days of diagnosis in patients with Cushing’s syndrome: results from the ERCUSYN registry. European Journal of Endocrinology, 181(5), 461-472.
Iqbal A & Newell-Price J (2019) Therapy of mild cortisol excess. Current Opinion in Endocrine and Metabolic Research, 8, 183-188.
Biller BMK, Newell-Price J, Fleseriu M, Bertagna X, Findling J, Shimatsu A, Lee EJ, Gu F, Auchus R, Leelawattana R , Lacroix A et al (2019) OR16-2 Osilodrostat Treatment in Cushing's Disease (CD): Results from a Phase III, Multicenter, Double-Blind, Randomized Withdrawal Study (LINC 3). Journal of the Endocrine Society, 3(Supplement_1).
Feelders RA, Newell-Price J, Pivonello R, Nieman LK, Hofland LJ & Lacroix A (2019) Advances in the medical treatment of Cushing's syndrome. The Lancet Diabetes & Endocrinology, 7(4), 300-312.
Sims-Williams H, Rajapaksa K, Sinha S, Radatz M, Walton L, Yianni J & Newell-Price J (2019) P45 Gamma knife radiosurgery for the primary management of acromegaly. Journal of Neurology, Neurosurgery & Psychiatry, 90(3), e36.2-e36.
Dromain C, Pavel ME, Ruszniewski P, Langley A, Massien C, Baudin E & Caplin ME (2019) Tumor growth rate as a metric of progression, response, and prognosis in pancreatic and intestinal neuroendocrine tumors. BMC Cancer, 19(1).
Sims-Williams HP, Rajapaksa K, Sinha S, Radatz M, Walton L, Yianni J & Newell-Price J (2019) Radiosurgery as primary management for acromegaly. Clinical Endocrinology, 90(1), 114-121.
Kelsall A & Newell-Price J (2019) Cushing's disease-from Minnie G to key issues in the early 21st century (vol 7, pg 959, 2019). LANCET DIABETES & ENDOCRINOLOGY, 7(12), E23-E23.
Harrison RF, Debono M, Whitaker MJ, Keevil BG, Newell-Price J & Ross RJ (2018) Salivary cortisone to estimate cortisol exposure and sampling frequency required based on serum cortisol measurements. Journal of Clinical Endocrinology and Metabolism. View this article in WRRO
Trainer PJ, Newell-Price J, Ayuk J, Aylwin S, Rees DA, Drake W, Chanson P, Brue T, Webb SM, Montañana CF , Aller J et al (2018) A randomised, open-label, parallel group phase 2 study of antisense oligonucleotide therapy in acromegaly. European Journal of Endocrinology, 179(2). View this article in WRRO
Foulkes E & Newell-Price J (2018) New Molecular Targets for Treatment of Cushing’s Disease. Endocrinology and Metabolism Clinics of North America, 47(2), 367-373.
Daniel E, Debono M, Caunt S, Girio-Fragkoulakis C, Walters SJ, Akker SA, Grossman AB, Trainer PJ & Newell-Price J (2018) A prospective longitudinal study of Pasireotide in Nelson’s syndrome. Pituitary, 21(3), 247-255. View this article in WRRO
Valassi E, Franz H, Brue T, Feelders RA, Netea-Maier R, Tsagarakis S, Webb SM, Yaneva M, Reincke M, Droste M , Komerdus I et al (2018) Preoperative medical treatment in Cushing’s syndrome: frequency of use and its impact on postoperative assessment: data from ERCUSYN. European Journal of Endocrinology, 178(4), 399-409.
Valassi E, Feelders R, Maiter D, Chanson P, Yaneva M, Reincke M, Krsek M, Tóth M, Webb SM, Santos A , Paiva I et al (2018) Worse Health-Related Quality of Life at long-term follow-up in patients with Cushing's disease than patients with cortisol producing adenoma. Data from the ERCUSYN. Clinical Endocrinology, 88(6), 787-798.
McCormack A, Dekkers OM, Petersenn S, Popovic V, Trouillas J, Raverot G, Burman P, _ _, _ _, Hubalewska-Dydejezky A , Assie G et al (2018) Treatment of aggressive pituitary tumours and carcinomas: results of a European Society of Endocrinology (ESE) survey 2016. European Journal of Endocrinology, 178(3), 265-276.
Altieri B, Muscogiuri G, Paschou SA, Vryonidou A, Della Casa S, Pontecorvi A, Fassnacht M, Ronchi CL & Newell-Price J (2018) Correction to: Adrenocortical incidentalomas and bone: from molecular insights to clinical perspectives. Endocrine, 62(3), 517-518.
Altieri B, Muscogiuri G, Paschou SA, Vryonidou A, Della Casa S, Pontecorvi A, Fassnacht M, Ronchi CL & Newell-Price J (2018) Adrenocortical incidentalomas and bone: from molecular insights to clinical perspectives. Endocrine, 62(3), 506-516.
Hawley JM, Owen LJ, Debono M, Newell-Price J & Keevil BG (2018) Development of a rapid liquid chromatography tandem mass spectrometry method for the quantitation of serum dexamethasone and its clinical verification. Annals of Clinical Biochemistry: International Journal of Laboratory Medicine, 55(6), 665-672.
Lacroix A, Gu F, Gallardo W, Pivonello R, Yu Y, Witek P, Boscaro M, Salvatori R, Yamada M, Tauchmanova L , Roughton M et al (2018) Efficacy and safety of once-monthly pasireotide in Cushing's disease: a 12 month clinical trial. The Lancet Diabetes and Endocrinology, 6(1), 17-26. View this article in WRRO
Kerr DE, Wenham T & Newell-Price J (2017) Endocrine problems in the critically ill 2: endocrine emergencies. BJA Education, 17(11), 377-382.
Amarawardena WKMG, Liyanarachchi KD, Newell-Price JDC, Ross RJM, Iacovazzo D & Debono M (2017) Pasireotide: successful treatment of a sparsely granulated tumour in a resistant case of acromegaly. Endocrinology, Diabetes & Metabolism Case Reports. View this article in WRRO
Debono M, Harrison RF, Chadarevian R, Gueroult C, Abitbol J-L & Newell-Price J (2017) Resetting the Abnormal Circadian Cortisol Rhythm in Adrenal Incidentaloma Patients With Mild Autonomous Cortisol Secretion. Journal of Clinical Endocrinology & Metabolism, 102(9), 3461-3469. View this article in WRRO
Newell-Price J & Chowdhury TA (2017) CME Endocrinology (108461): self-assessment questionnaire. Clinical Medicine, 17(3), 278-279.
Daniel E & Newell-Price J (2017) Recent advances in understanding Cushing disease: resistance to glucocorticoid negative feedback and somatic USP8 mutations. F1000Research, 6, 613-613. View this article in WRRO
Liyanarachchi K, Amarawardena M, Newell-Price J, Ross R & Debono M (2017) Pasireotide: successful treatment of a resistant case of Acromegaly. Endocrine Abstracts, 48. View this article in WRRO
Daniel E & Newell-Price J (2017) Cushing's syndrome. Medicine, 45(8), 475-479.
Daniel E, Jones R, Bull M & Newell-Price J (2016) Rapid-sequence MRI for long-term surveillance for paraganglioma and phaeochromocytoma in patients with succinate dehydrogenase mutations. European Journal of Endocrinology, 175, 561-570. View this article in WRRO
Speak R, Cook J, Harrison B & Newell-Price J (2016) Disease-modifying polymorphisms and C609Y mutation of RET associated with high penetrance of phaeochromocytoma and low rate of MTC in MEN2A. Endocrinology, Diabetes & Metabolism Case Reports. View this article in WRRO
Findling JW, Fleseriu M, Newell-Price J, Petersenn S, Pivonello R, Kandra A, Pedroncelli AM & Biller BMK (2016) Late-night salivary cortisol may be valuable for assessing treatment response in patients with Cushing’s disease: 12-month, Phase III pasireotide study. Endocrine, 54(2), 516-523. View this article in WRRO
Fassnacht M, Arlt W, Bancos I, Dralle H, Newell-Price J, Sahdev A, Tabarin A, Terzolo M, Tsagarakis S & Dekkers OM (2016) Management of adrenal incidentalomas: European Society of Endocrinology Clinical Practice Guideline in collaboration with the European Network for the Study of Adrenal Tumors. European Journal of Endocrinology, 175(2), G1-G34.
Newell-Price J (2016) Pituitary gland: Mortality in Cushing disease. Nature Reviews Endocrinology, 12(9), 502-503.
Pivonello R, Isidori AM, De Martino MC, Newell-Price J, Biller BMK & Colao A (2016) Complications of Cushing's syndrome: state of the art. The Lancet Diabetes & Endocrinology, 4(7), 611-629.
Jones R, McDonald KE, Willson JA, Ghesquière B, Sammut D, Daniel E, Harris AJ, Lewis A, Thompson AAR, Dickinson RS , Plant T et al (2016) Mutations in succinate dehydrogenase B (SDHB) enhance neutrophil survival independent of HIF-1α expression. Blood, 127(21), 2641-2644. View this article in WRRO
Debono M & Newell-Price JD (2016) Cushing's Syndrome: Where and How to Find It. Frontiers of Hormone Research, 46, 15-27.
Palazzo F, Dickinson A, Phillips B, Sahdev A, Bliss R, Rasheed A, Krukowski Z & Newell-Price J (2016) Adrenal surgery in England: Better Outcomes in High Volume Practices. Clinical Endocrinology, 85(1), 17-20.
Daniel E, Aylwin S, Mustafa O, Ball S, Munir A, Boelaert K, Chortis V, Cuthbertson DJ, Daousi C, Rajeev SP , Davis J et al (2015) Effectiveness of Metyrapone in Treating Cushing's Syndrome: A Retrospective Multicenter Study in 195 Patients. The Journal of Clinical Endocrinology & Metabolism, 100(11), 4146-4154. View this article in WRRO
Wolin E, Jarzab B, Eriksson B, Walter T, Toumpanakis C, Morse MA, Tomassetti P, Weber MM, Fogelman D, Ramage J , Poon D et al (2015) Phase III study of pasireotide long-acting release in patients with metastatic neuroendocrine tumors and carcinoid symptoms refractory to available somatostatin analogues. Drug Design, Development and Therapy, 9, 5075-5075. View this article in WRRO
Nieman LK, Biller BMK, Findling JW, Murad MH, Newell-Price J, Savage MO & Tabarin A (2015) Treatment of Cushing's Syndrome: An Endocrine Society Clinical Practice Guideline. The Journal of Clinical Endocrinology & Metabolism, 100(8), 2807-2831.
Debono M & Newell-Price J (2015) Subclinical hypercortisolism in adrenal incidentaloma. Current Opinion in Endocrinology & Diabetes and Obesity, 22(3), 185-192.
Daniel E & Newell-Price JDC (2015) Diagnosis of Cushing’s disease. Pituitary, 18(2), 206-210.
Bevan J, Newell-Price J, Reynolds R, de Herder W, Anawalt B, Ebeling P & Ball S (2015) Clinical EndocrinologyEducation Project: a tribute to Professor Steve Judd. Clinical Endocrinology, 82(5), 623-623.
Daniel E & Newell-Price JDC (2015) THERAPY OF ENDOCRINE DISEASE: Steroidogenesis enzyme inhibitors in Cushing's syndrome. European Journal of Endocrinology, 172(6), R263-R280.
Debono M, Bradburn M, Bull M, Harrison B, Ross RJ & Newell-Price J (2014) Cortisol as a Marker for Increased Mortality in Patients with Incidental Adrenocortical Adenomas. The Journal of Clinical Endocrinology & Metabolism, 99(12), 4462-4470.
Robins JMW, Ayuk J, Newell-Price JDC & UK NAI2 (2014) Effectiveness of Stereotactic Gamma Knife Radiosurgery for the Treatment of Acromegaly. ENDOCRINE REVIEWS, 35(3).
Daniel E, Bull MJ, Jones RA & Newell-Price JDC (2014) Rapid-Sequence MRI for Long-Term Monitoring of Succinate Dehydrogenase (SDHx) Mutation Carriers. ENDOCRINE REVIEWS, 35(3).
Adaway J, Debono M, Newell-Price JDC & Keevil BG (2014) Biological Variability of Plasma 5-Hiaa. ENDOCRINE REVIEWS, 35(3).
Daniel E, Aylwin SJB, Ball SG, Boelaert K, Cuthbertson D, Daousi C, Davis JR, Drake W, Grossman AB, Gurnell M , Karavitaki N et al (2014) Clinical Effectiveness of Metyrapone Monotherapy in 195 Patients with Cushing's Syndrome. ENDOCRINE REVIEWS, 35(3).
Newell-Price J (2014) Ketoconazole as an adrenal steroidogenesis inhibitor: effectiveness and risks in the treatment of Cushing's disease.. J Clin Endocrinol Metab, 99(5), 1586-1588.
Pivonello R, Petersenn S, Newell-Price J, Findling JW, Gu F, Maldonado M, Trovato A, Hughes G, Salgado LR, Lacroix A , Schopohl J et al (2014) Pasireotide treatment significantly improves clinical signs and symptoms in patients with Cushing's disease: results from a Phase III study.. Clin Endocrinol (Oxf), 81(3), 408-417.
Petersenn S, Newell-Price J, Findling JW, Gu F, Maldonado M, Sen K, Salgado LR, Colao A, Biller BMK & Pasireotide B2305 Study Group (2014) High variability in baseline urinary free cortisol values in patients with Cushing's disease.. Clin Endocrinol (Oxf), 80(2), 261-269. View this article in WRRO
Iqbal J, Parviz Y, Pitt B, Newell-Price J, Al-Mohammad A & Zannad F (2014) Selection of a mineralocorticoid receptor antagonist for patients with hypertension or heart failure.. Eur J Heart Fail, 16(2), 143-150.
Daniel E & Newell-Price J (2013) Cushing's syndrome. Medicine (United Kingdom), 41(9), 508-511.
Wolin EM, Jarzab B, Eriksson B, Walter T, Toumpanakis C, Morse M, Tomassetti P, Weber M, Fogelman DR, Ramage J , Poon D et al (2013) A multicenter, randomized, blinded, phase III study of pasireotide LAR versus octreotide LAR in patients with metastatic neuroendocrine tumors (NET) with disease-related symptoms inadequately controlled by somatostatin analogs.. Journal of Clinical Oncology, 31(15_suppl), 4031-4031.
Debono M, Prema A, Hughes TJB, Bull M, Ross RJ & Newell-Price J (2013) Visceral fat accumulation and postdexamethasone serum cortisol levels in patients with adrenal incidentaloma.. J Clin Endocrinol Metab, 98(6), 2383-2391.
Walsh JS, Newell-Price JD, DeBono M, Adaway J, Keevil B & Eastell R (2013) Circulating serotonin and bone density, structure, and turnover in carcinoid syndrome.. J Clin Endocrinol Metab, 98(7), 2902-2907.
Debono M, Chadarevian R, Eastell R, Ross RJ & Newell-Price J (2013) Mifepristone reduces insulin resistance in patient volunteers with adrenal incidentalomas that secrete low levels of cortisol: a pilot study.. PLoS One, 8(4), e60984. View this article in WRRO
Li W, Newell-Price J, Jones GL, Ledger WL & Li TC (2012) Relationship between psychological stress and recurrent miscarriage.. Reprod Biomed Online, 25(2), 180-189.
Colao A, Petersenn S, Newell-Price J, Findling JW, Gu F, Maldonado M, Schoenherr U, Mills D, Salgado LR, Biller BMK & Pasireotide B2305 Study Group (2012) A 12-month phase 3 study of pasireotide in Cushing's disease.. N Engl J Med, 366(10), 914-924.
Higham CE, Atkinson AB, Aylwin S, Bidlingmaier M, Drake WM, Lewis A, Martin NM, Moyes V, Newell-Price J & Trainer PJ (2012) Effective combination treatment with cabergoline and low-dose pegvisomant in active acromegaly: a prospective clinical trial.. J Clin Endocrinol Metab, 97(4), 1187-1193.
Higham CE, Atkinson AB, Aylwin S, Bidlingmaier M, Drake WM, Lewis A, Martin NM, Moyes V, Newell-Price J & Trainer PJ (2012) Effective combination treatment with cabergoline and low-dose pegvisomant in active acromegaly: A prospective clinical trial: Editorial Comment. Obstetrical and Gynecological Survey, 67(8), 475-477.
Ramage JK, Ahmed A, Ardill J, Bax N, Breen DJ, Caplin ME, Corrie P, Davar J, Davies AH, Lewington V , Meyer T et al (2012) Guidelines for the management of gastroenteropancreatic neuroendocrine (including carcinoid) tumours (NETs).. Gut, 61(1), 6-32.
Newell-Price J (2011) Whither pituitary incidentaloma?. J Clin Endocrinol Metab, 96(4), 939-941.
Debono M, Sheppard L, Irving S, Jackson P, Butterworth J, Brookes ZLS, Newell-Price J, Ross JJ & Ross RJ (2011) Assessing adrenal status in patients before and immediately after coronary artery bypass graft surgery.. Eur J Endocrinol, 164(3), 413-419.
Debono M & Newell-Price J (2010) New formulations and approaches in the medical treatment of acromegaly.. Curr Opin Endocrinol Diabetes Obes, 17(4), 350-355.
Munir A & Newell-Price J (2010) Management of diabetes mellitus in Cushing's syndrome.. Neuroendocrinology, 92 Suppl 1, 82-85.
Newell-Price J (2009) Diagnosis/differential diagnosis of Cushing's syndrome: a review of best practice.. Best Pract Res Clin Endocrinol Metab, 23 Suppl 1, S5-14.
Perogamvros I, Owen LJ, Newell-Price J, Ray DW, Trainer PJ & Keevil BG (2009) Simultaneous measurement of cortisol and cortisone in human saliva using liquid chromatography-tandem mass spectrometry: application in basal and stimulated conditions.. J Chromatogr B Analyt Technol Biomed Life Sci, 877(29), 3771-3775.
Newell-Price J (2009) Adrenal gland: Hypertension during remission of childhood Cushing syndrome.. Nat Rev Endocrinol, 5(11), 591-592.
Debono M, Ross RJ & Newell-Price J (2009) Inadequacies of glucocorticoid replacement and improvements by physiological circadian therapy.. Eur J Endocrinol, 160(5), 719-729.
Debono M, Ghobadi C, Rostami-Hodjegan A, Huatan H, Campbell MJ, Newell-Price J, Darzy K, Merke DP, Arlt W & Ross RJ (2009) Modified-release hydrocortisone to provide circadian cortisol profiles.. J Clin Endocrinol Metab, 94(5), 1548-1554. View this article in WRRO
Newell-Price J (2009) Cushing's Disease, 253-261.
Munir A & Newell-Price J (2009) Cushing's syndrome. Medicine, 37(8), 403-406.
Biller BMK, Grossman AB, Stewart PM, Melmed S, Bertagna X, Bertherat J, Buchfelder M, Colao A, Hermus AR, Hofland LJ , Klibanski A et al (2008) Treatment of adrenocorticotropin-dependent Cushing's syndrome: A consensus statement. J CLIN ENDOCR METAB, 93(7), 2454-2462.
Munir A, Choudhary P, Harrison B, Heller S & Newell-Price J (2008) Continuous glucose monitoring in patients with insulinoma.. Clin Endocrinol (Oxf), 68(6), 912-918.
Debono M, Hon L-Q, Bax N, Blakeborough A & Newell-Price J (2008) Gluteal nodules in patients with metastatic midgut carcinoid disease treated with depot somatostatin analogs.. J Clin Endocrinol Metab, 93(5), 1860-1864.
Nieman LK, Biller BMK, Findling JW, Newell-Price J, Savage MO, Stewart PM & Montori VM (2008) The diagnosis of Cushing's syndrome: an Endocrine Society Clinical Practice Guideline.. J Clin Endocrinol Metab, 93(5), 1526-1540.
Newell-Price J (2008) Cushing's syndrome.. Clin Med (Lond), 8(2), 204-208.
Newell-Price J (2008) Diagnosis of Cushing's syndrome: comparison of the specificity of first-line biochemical tests.. Nat Clin Pract Endocrinol Metab, 4(4), 192-193.
Bates PR, Carson MN, Trainer PJ, Wass JAH, Bevan JS, Atkinson AB, Peacey SR, Stewart PM, Sheppard MC, Dayan CM , Chatterjee K et al (2008) Wide variation in surgical outcomes for acromegaly in the UK. Clinical Endocrinology, 68(1), 136-142.
Newell-Price J, Whiteman M, Rostami-Hodjegan A, Darzy K, Shalet S, Tucker GT & Ross RJM (2008) Modified-release hydrocortisone for circadian therapy: a proof-of-principle study in dexamethasone-suppressed normal volunteers.. Clin Endocrinol (Oxf), 68(1), 130-135.
Bevan JS, Newell-Price J, Wass JAH, Atkin SL, Bouloux PM, Chapman J, Davis JRE, Howlett TA, Randeva HS, Stewart PM & Viswanath A (2008) Home administration of lanreotide Autogel by patients with acromegaly, or their partners, is safe and effective.. Clin Endocrinol (Oxf), 68(3), 343-349. View this article in WRRO
Newell-Price J & Grossman AB (2007) Differential diagnosis of Cushing's syndrome.. Arq Bras Endocrinol Metabol, 51(8), 1199-1206.
Munir A & Newell-Price J (2007) Nelson's Syndrome.. Arq Bras Endocrinol Metabol, 51(8), 1392-1396.
Kater CE, Vilar L & Newell-Price J (2007) Harvey Cushing and Philip Hench: pituitary basophilism meets cortisone excess.. Arq Bras Endocrinol Metabol, 51(8), 1182-1184.
Munir A, Song F, Ince P, Walters SJ, Ross R & Newell-Price J (2007) Ineffectiveness of rosiglitazone therapy in Nelson's syndrome.. J Clin Endocrinol Metab, 92(5), 1758-1763.
Merza Z, Rostami-Hodjegan A, Memmott A, Doane A, Ibbotson V, Newell-Price J, Tucker GT & Ross RJ (2006) Circadian hydrocortisone infusions in patients with adrenal insufficiency and congenital adrenal hyperplasia.. Clin Endocrinol (Oxf), 65(1), 45-50.
Newell-Price J, Bertagna X, Grossman AB & Nieman LK (2006) Cushing's syndrome.. Lancet, 367(9522), 1605-1617.
Isidori AM, Kaltsas GA, Pozza C, Frajese V, Newell-Price J, Reznek RH, Jenkins PJ, Monson JP, Grossman AB & Besser GM (2006) The ectopic adrenocorticotropin syndrome: clinical features, diagnosis, management, and long-term follow-up.. J Clin Endocrinol Metab, 91(2), 371-377.
Selvarajah D, Webster J, Ross R & Newell-Price J (2005) Effectiveness of adding dopamine agonist therapy to long-acting somatostatin analogues in the management of acromegaly.. Eur J Endocrinol, 152(4), 569-574.
Selvarajah D, Webster J, Ross R & Newell-Price J (2005) Effectiveness of combined dopamine agonist and long-acting somatostatin analogues in the management of resistant acromegaly. EUR J ENDOCRINOL, 152.
Newell-Price J (2005) Cushing's syndrome. Medicine, 33(11), 11-13.
Savage MW, Mah PM, Weetman AP & Newell-Price J (2004) Endocrine emergencies.. Postgrad Med J, 80(947), 506-515.
Mah PM, Jenkins RC, Rostami-Hodjegan A, Newell-Price J, Doane A, Ibbotson V, Tucker GT & Ross RJ (2004) Weight-related dosing, timing and monitoring hydrocortisone replacement therapy in patients with adrenal insufficiency.. Clin Endocrinol (Oxf), 61(3), 367-375.
Arnaldi G, Angeli A, Atkinson AB, Bertagna X, Cavagnini F, Chrousos GP, Fava GA, Findling JW, Gaillard RC, Grossman AB , Kola B et al (2003) Diagnosis and complications of Cushing's syndrome: A consensus statement. J CLIN ENDOCR METAB, 88(12), 5593-5602.
Newell-Price J (2003) Managing adrenal disorders.. Practitioner, 247(1648), 588-592.
Merza Z, Edwards N, Walters SJ, Newell-Price J & Ross RJM (2003) Patients with chronic pain and abnormal pituitary function require investigation.. Lancet, 361(9376), 2203-2204.
Newell-Price J (2003) Proopiomelanocortin gene expression and DNA methylation: implications for Cushing's syndrome and beyond.. J Endocrinol, 177(3), 365-372.
Mah PM, Jenkins RC, Rostami-Hodjegan A, Newell-Price J, Doane A, Ibbotson V, Tucker G & Ross RJ (2002) Optimisation of Hydrocortisone Replacement Therapy. Clinical Science, 103(s47), 24P-24P.
Newell-Price J & Grossman A (2002) Biochemical and imaging evaluation of Cushing's syndrome.. Minerva Endocrinol, 27(2), 95-118.
Newell-Price J, Morris DG, Drake WM, Korbonits M, Monson JP, Besser GM & Grossman AB (2002) Optimal response criteria for the human CRH test in the differential diagnosis of ACTH-dependent Cushing's syndrome.. J Clin Endocrinol Metab, 87(4), 1640-1645.
Newell-Price J (2002) Transsphenoidal surgery for Cushing's disease: defining cure and following outcome.. Clin Endocrinol (Oxf), 56(1), 19-21.
Newell-Price J & Weetman AP (2002) Endocrine emergencies. CPD Journal Acute Medicine, 1(1), 4-8.
Newell-Price J & Grossman AB (2001) The differential diagnosis of Cushing's syndrome.. Ann Endocrinol (Paris), 62(2), 173-179.
Newell-Price J, King P & Clark AJ (2001) The CpG island promoter of the human proopiomelanocortin gene is methylated in nonexpressing normal tissue and tumors and represses expression.. Mol Endocrinol, 15(2), 338-348.
Newell-Price J, Clark AJ & King P (2000) DNA methylation and silencing of gene expression.. Trends Endocrinol Metab, 11(4), 142-148.
Kaltsas GA, Newell-Price JD, Trainer PJ, Besser GM & Grossman AB (2000) Complications of inferior petrosel sinus sampling.. J Clin Endocrinol Metab, 85(4), 1741.
Newell-Price J & Grossman A (1999) Diagnosis and management of Cushing's syndrome.. Lancet, 353(9170), 2087-2088.
Dinan TG, Lavelle E, Scott LV, Newell-Price J, Medbak S & Grossman AB (1999) Desmopressin normalizes the blunted adrenocorticotropin response to corticotropin-releasing hormone in melancholic depression: evidence of enhanced vasopressinergic responsivity.. J Clin Endocrinol Metab, 84(6), 2238-2240.
Sohaib SA, Hanson JA, Newell-Price JD, Trainer PJ, Monson JP, Grossman AB, Besser GM & Reznek RH (1999) CT appearance of the adrenal glands in adrenocorticotrophic hormone-dependent Cushing's syndrome.. AJR Am J Roentgenol, 172(4), 997-1002.
Hanson JA, Sohaib SA, Newell-Price J, Islam N, Monson JP, Trainer PJ, Grossman A, Besser GM & Reznek RH (1999) Computed tomography appearance of the thymus and anterior mediastinum in active Cushing's syndrome.. J Clin Endocrinol Metab, 84(2), 602-605.
Kaltsas GA, Giannulis MG, Newell-Price JD, Dacie JE, Thakkar C, Afshar F, Monson JP, Grossman AB, Besser GM & Trainer PJ (1999) A critical analysis of the value of simultaneous inferior petrosal sinus sampling in Cushing's disease and the occult ectopic adrenocorticotropin syndrome.. J Clin Endocrinol Metab, 84(2), 487-492.
Newell-Price J & Trainer PJ (1999) The pituitary adrenal axis. Frontiers of Hormone Research, 24, 110-130.
Newell-Price J, Jorgensen JO & Grossman A (1999) The diagnosis and differential diagnosis of Cushing's syndrome.. Horm Res, 51 Suppl 3, 81-94.
Newell-Price J, Trainer P, Besser M & Grossman A (1998) The diagnosis and differential diagnosis of Cushing's syndrome and pseudo-Cushing's states.. Endocr Rev, 19(5), 647-672.
Lado-Abeal J, Rodriguez-Arnao J, Newell-Price JD, Perry LA, Grossman AB, Besser GM & Trainer PJ (1998) Menstrual abnormalities in women with Cushing's disease are correlated with hypercortisolemia rather than raised circulating androgen levels.. J Clin Endocrinol Metab, 83(9), 3083-3088.
Newell-Price J (1997) The desmopressin test and Cushing's syndrome: current state of play.. Clin Endocrinol (Oxf), 47(2), 173-174.
Newell-Price J, Perry L, Medbak S, Monson J, Savage M, Besser M & Grossman A (1997) A combined test using desmopressin and corticotropin-releasing hormone in the differential diagnosis of Cushing's syndrome.. J Clin Endocrinol Metab, 82(1), 176-181.
Caulfield M, Lavender P, Newell-Price J, Kamdar S, Farrall M & Clark AJ (1996) Angiotensinogen in human essential hypertension.. Hypertension, 28(6), 1123-1125.
Newell-Price J & Grossman A (1996) Adrenal incidentaloma: subclinical Cushing's syndrome.. Postgrad Med J, 72(846), 207-210.
Newell-Price J, Trainer P, Perry L, Wass J, Grossman A & Besser M (1995) A single sleeping midnight cortisol has 100% sensitivity for the diagnosis of Cushing's syndrome.. Clin Endocrinol (Oxf), 43(5), 545-550.
Caulfield M & Newell-Price J (1995) The angiotensin converting enzyme gene in cardiovascular disease.. Br Heart J, 74(3), 207-208.
Caulfield M, Lavender P, Newell-Price J, Farrall M, Kamdar S, Daniel H, Lawson M, De Freitas P, Fogarty P & Clark AJ (1995) Linkage of the angiotensinogen gene locus to human essential hypertension in African Caribbeans.. J Clin Invest, 96(2), 687-692.
Trainer PJ, Faria M, Newell-Price J, Browne P, Kopelman P, Coy DH, Besser GM & Grossman AB (1995) A comparison of the effects of human and ovine corticotropin-releasing hormone on the pituitary-adrenal axis.. J Clin Endocrinol Metab, 80(2), 412-417.
Prete A, Theiler-Schwetz V, Arlt W, Chifu I-O, Harbeck B, Napier C, Newell-Price JDC, Rees A, Reisch N, Stalla GK , Aslam N et al () Morning cortisol levels in patients with established primary adrenal insufficiency. Endocrine Abstracts.
Prete A, Theiler-Schwetz V, Arlt W, Chifu I-O, Harbeck B, Napier C, Newell-Price JDC, Rees A, Reisch N, Stalla GK , Aslam N et al () CHAMPAIN study: Initial results from a phase II study of efficacy, safety and tolerability of modified-release hydrocortisones: Chronocort® (Efmody®) versus Plenadren®, in primary adrenal insufficiency. Endocrine Abstracts.
John MRR, Merke DP, Mallappa A, Arlt W, DeLaPerriere A, Hirschberg A, Newell-Price JDC, Prete A, Rees A, Reisch N , Quinkler M et al () Incidence of adrenal crisis in Congenital Adrenal Hyperplasia (CAH) patients during a prospective monitored long-term study of modified-release hydrocortisone (MRHC) capsules, (Efmody). Endocrine Abstracts.
John MRR, Merke DP, Arlt W, De LPAB, Hirschberg A, Newell-Price JDC, Prete A, Rees A, Reisch N, Quinkler M , Touraine PA et al () Biochemical control with dose reduction in chronic glucocorticoid therapy over 4 years: A phase III extension study of Chronocort (Efmody) in the treatment of Congenital Adrenal Hyperplasia (CAH). Endocrine Abstracts.
Pivonello R, Fleseriu M, Newell-Price J, Shimatsu A, Feelders RA, Kadioglu P, Tabarin A, Brue TC, Geer EB, Piacentini A , Pedroncelli AM et al () Improvement in clinical features of hypercortisolism during osilodrostat treatment: findings from the Phase III LINC 3 trial in Cushing's disease. Journal of Endocrinological Investigation.
Arima H, Cheetham T, Christ‐Crain M, Cooper D, Drummond J, Gurnell M, Levy M, McCormack A, Newell‐Price J, Verbalis JG & Wass J () Changing the name of diabetes insipidus: a position statement of the working group to consider renaming diabetes insipidus. Clinical Endocrinology.
Hillary SL, Chooi JE, Wadsley J, Newell-Price JD, Brown NJ & Balasubramanian SP () Quality of Life in Post-Surgical Hypoparathyroidism (PoSH) in Thyroid and Parathyroid Surgery. World Journal of Surgery.
Arima H, Cheetham T, Christ-Crain M, Cooper DL, Drummond JB, Gurnell M, Levy M, McCormack A, Newell-Price JD, Verbalis JG & Wass J () Changing the Name of Diabetes Insipidus: A Position Statement of the Working Group to Consider Renaming Diabetes Insipidus. Hormone Research in Paediatrics, 1-3.
Kelsall A & Newell-Price J () Cushing Mortality in Remission: Not Out of the Woods. The Journal of Clinical Endocrinology & Metabolism.
Tschaidse L, Reisch N, Arlt W, Brac DLPA, Linden HA, Juul A, Mallappa A, Merke DP, Newell-Price JDC, Perry CG , Prete A et al () Improved biochemical control with modified-release hydrocortisone overturns the impaired fludrocortisone effect in salt-wasting CAH patients. Endocrine Abstracts.
Tschaidse L, Quinkler M, Arlt W, Brac DLPA, Linden HA, Juul A, Mallappa A, Merke DP, Newell-Price JDC, Perry CG , Prete A et al () Fertility in congenital adrenal hyperplasia (CAH) patients on modified release hydrocortisone capsules (MRHC, Efmody). Endocrine Abstracts.
Maynard A, Hill S, Hallam A, Sabbagh A, Brown C, Munir A, Newell-Price J & Wadsley J () Sheffield experience of administering Lutathera as a day case treatment. Endocrine Abstracts.
Wass J, Newell-Price J & Arlt W () Consider Addison’s disease in differential diagnosis of eating disorders in children and young people. BMJ, k277-k277.
Rajapaksa K, Sims-Williams HP, Yianni J, Sinha S & Newell-Price J () Long-term safety of gamma knife radiosurgery (STRS) for acromegaly. Endocrine Abstracts.
Amarawardena WKMG, Liyanarachchi KD, Newell-Price JDC, Ross RJM & Debono M () Pasireotide: an effective treatment for resistant acromegaly. Endocrine Abstracts.
Liyanarachchi K, Amarawardena M, Smith E, Newell-Price J & Munir A () Low rate of psychological ill health in patients with GEP NETS attending an ENETS Centre of Excellence. Endocrine Abstracts.
Liyanarachchi K, Amarawardena M, Lorenz E, Newell-Price J & Munir A () Cardiac metastases from ileal NETs. Endocrine Abstracts.
Debono M, Harrison R, Chadarevian R, Gueroult C, Abitbol J-L & Newell-Price J () Restoring the circadian cortisol rhythm with metyrapone in patients with adrenal incidentalomas and subclinical hypercortisolism reduces IL6 levels. Endocrine Abstracts.
Bakirtzi G & Newell-Price J () Chronic glucocorticoid exposure inhibits expression of the pomc activator, tpit, by inducing de-novo DNA methylation. Endocrine Abstracts.
Elhassan YM, Foran B, Hodgson T, Ince P, Sinha S & Newell-Price J () Follow-up, surgery and proton beam therapy for a pituitary sella chondrosarcoma. Endocrine Abstracts.
Debono M, Newell-Price J, Hawley J & Keevil B () Measurement of dexamethasone by LC-MS/MS after a 1 mg overnight dexamethasone suppression test. Endocrine Abstracts.
Daniel E, Aylwin S, Mustafa O, Ball S, Munir A, Boelaert K, Chortis V, Cuthbertson DJ, Daousi C, Rajeev S , Davis J et al () Effectiveness of metyrapone in 195 patients with Cushing's syndrome. Endocrine Abstracts.

Chapters

Kelsall A & Newell-Price J (2021) Medical management of Cushing's disease, Pituitary Tumors (pp. 231-244). Elsevier
Newell-Price JDC (2017) Cushing Disease, The Pituitary (pp. 515-571). Elsevier
Beckers A, Ben-Shlomo A, Bichet DG, Binart N, Bonert VS, Bronstein MD, Buchfelder M, Carmichael JD, Chanson P, Daly AF , Donoho DA et al (2017) List of Contributors, The Pituitary (pp. ix-ix). Elsevier
Newell-Price JDC (2017) Cushing Disease, The Pituitary: Fourth Edition (pp. 515-571).
Stewart PM & Newell-Price JDC (2016) The Adrenal Cortex, Williams Textbook of Endocrinology (pp. 489-555). Elsevier
Newell-Price J (2010) Etiologies of Cushing’s Syndrome, Cushing's Syndrome (pp. 21-29). Humana Press

Conference proceedings papers

Lawrence NR, Bacila I, Dawson J, Ali SR, van den Akker ELT, Sartori Sanchez Bachega TA, Baronio F, Birkebaek NH, Bonfig W, van der Grinten C , Cools M et al (2022) Blood pressure (BP) status in Congenital Adrenal Hyperplasia (CAH) - longitudinal analysis of real world data from the I-CAH registry. HORMONE RESEARCH IN PAEDIATRICS, Vol. 95(SUPPL 2) (pp 112-113)
Hillary S, Glenister E, Chooi JE, Farnell K, Grey J, Wadsley J, Newell-Price J, Brown N & Balasubramanian S (2022) Quality of life in post-surgical hypoparathyroidism (PoSH). BRITISH JOURNAL OF SURGERY, Vol. 109
Arshad MF, Kaluarachchi V, Iqbal A, Munir A & Newell-Price JDC (2020) SUN-299 Flash Glucose Sensor Monitoring for Patients with Endogenous Hyperinsulinaemic Hypoglycaemia. Journal of the Endocrine Society, Vol. 4(Supplement_1)
Ross RJ, Harrison RF, Debono M, Whitaker MJ, Keevil BG & Newell-Price J (2017) SERUM CORTISOL AND SALIVARY CORTISONE AND FREQUENCY OF SAMPLING TO ESTIMATE CORTISOL EXPOSURE. HORMONE RESEARCH IN PAEDIATRICS, Vol. 88 (pp 53-54)
Robins JM, Ayuk J, Trainer PJ & Newell-Price J (2014) Stereotactic gamma knife radiosurgery as an effective treatment for acromegaly. Journal of the American College of Surgeons, Vol. 219(4) (pp e24-e24)
Wolin EM, Jarzab B, Eriksson B, Walter T, Toumpanakis C, Morse M, Tomassetti P, Weber M, Fogelman DR, Ramage J , Poon D et al (2013) A multicenter, randomized, blinded, phase III study of pasireotide LAR versus octreotide LAR in patients with metastatic neuroendocrine tumors (NET) with disease-related symptoms inadequately controlled by somatostatin analogs. JOURNAL OF CLINICAL ONCOLOGY, Vol. 31(15)
Walsh J, Newell-Price J, Debono M & Eastell R (2012) HIGH CIRCULATING SEROTONIN IN CARCINOID SYNDROME IS NOT ASSOCIATED WITH ALTERATIONS IN BONE TURNOVER OR BONE DENSITY. OSTEOPOROSIS INTERNATIONAL, Vol. 23 (pp S536-S537)
Walsh JS, Newell-Price JD, Debono M & Eastell R (2012) High circulating serotonin in carcinoid syndrome is not associated with alterations in bone turnover or bone density. BONE, Vol. 50 (pp S53-S53)
Petersenn S, Newell-Price J, Findling JW, Gu F, Maldonado M, Sen K, Salgado LR, Colao A & Biller BMK (2010) Baseline Characteristics and Urine Free Cortisol (UFC) Variability of 162 Patients Enrolled in a Randomized, Double-Blind Phase III Study Assessing the Efficacy and Safety of Pasireotide (SOM230) in Patients with Cushing's Disease.. ENDOCRINE REVIEWS, Vol. 31(3)

Grants

Society for Endocrinology, £120,000, 2005-2008. RNA interference as therapy for models of Cushing's disease and acromegaly.
Sheffield Hospitals' Charitable Trust, £24,995, 2006-2008. RNA interference as therapy for models of Cushing's disease and acromegaly.
European Union, 450,000 Euros (Joint partner). European Register on Cushing's Syndrome, in Framework of Public Health Programme. 2007-2010.

Professional activities and memberships

National Committee Membership

Society for Endocrinology Clinical Subcommittee, 1997-2000.
Chair of the UK Medical Committee, Pituitary Foundation, UK, 2007.
UK and Ireland Neuroendocrine Tumour Society, Executive Officer, 2007.
UK Acromegaly Database Steering Committee, 2005-to date.

Editorship

Associate Editor of Clinical Endocrinology 2001-to date.
Editorial Board, Clinical Endocrinology, 2001-to date.
Editorial Board, Journal of Clinical Endocrinology and Metabolism, 2008-2010.

Advisory Boards

NICE Appraisal of Pituitary Disease, 2004-2005.

National and International Guidelines

Task Force Member (one of six) for the American Endocrine Society's Guidelines on the Diagnosis of Cushing's Syndrome.